TNXP

Tonix Pharmaceuticals Holding (TNXP)

About Tonix Pharmaceuticals Holding (TNXP)

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Details

Daily high

$14.14

Daily low

$13.52

Price at open

$13.70

52 Week High

$69.97

52 Week Low

$11.60

Market cap

193.5M

Dividend yield

0.00%

Volume

262,912

Avg. volume

422,698

P/E ratio

-.96

Tonix Pharmaceuticals Holding News